Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral Therapy | Zendy

Patricia M. Flynn | Zendy; Bret J. Rudy | Zendy; Steven D. Douglas | Zendy; Janet L. Lathey | Zendy; Stephen A. Spector | Zendy; Jaime Martinez | Zendy; Margarita Silió | Zendy; Marvin Belzer | Zendy; Lawrence B. Friedman | Zendy; Lawrence J. D’Angelo | Zendy; James McNamara | Zendy; Janice Hodge | Zendy; Michael D. Hughes | Zendy; Jane C. Lindsey | Zendy

Open Access

Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral Therapy

Author(s) -

Patricia M. Flynn,

Bret J. Rudy,

Steven D. Douglas,

Janet L. Lathey,

Stephen A. Spector,

Jaime Martinez,

Margarita Silió,

Marvin Belzer,

Lawrence B. Friedman,

Lawrence J. D’Angelo,

James McNamara,

Janice Hodge,

Michael D. Hughes,

Jane C. Lindsey

Publication year - 2004

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/421521

Subject(s) - antiretroviral therapy , medicine , sida , human immunodeficiency virus (hiv) , immunology , lentivirus , viral load , immunopathology , viral disease , virology

Adolescents represent the fastest growing demographic group of new human immunodeficiency virus (HIV) infections in the United States. At present, there is little information available about their response to therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research